Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1473-4230
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease ; day:8 ; month:10 ; year:2018 ; pages:1-13
The cerebellum ; (8.10.2018), 1-13
- Urheber
- Beteiligte Personen und Organisationen
-
Jech, Robert
Ballarini, Tommaso
Holiga, Štefan
Růžička, Filip
Piecha, Fabian A.
Möller, Harald E.
Vymazal, Josef
Růžička, Evžen
Schroeter, Matthias L.
SpringerLink (Online service)
- DOI
-
10.1007/s12311-018-0981-y
- URN
-
urn:nbn:de:101:1-2018111618521315273159
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mueller, Karsten
- Jech, Robert
- Ballarini, Tommaso
- Holiga, Štefan
- Růžička, Filip
- Piecha, Fabian A.
- Möller, Harald E.
- Vymazal, Josef
- Růžička, Evžen
- Schroeter, Matthias L.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cerebellar involvement in Parkinson’s disease resting tremor
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs
Charakteristika der Unified Parkinson’s Disease Rating Scale im Rahmen der Levodopa-Response
Levodopa-Responsive Primary Slow Orthostatic Tremor: A Premotor Sign of Parkinson’s Disease?
Model-based optimization of controlled release formulation of levodopa for Parkinson’s disease
Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
Cerebellar involvement in Parkinson’s disease resting tremor
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs
Charakteristika der Unified Parkinson’s Disease Rating Scale im Rahmen der Levodopa-Response
Levodopa-Responsive Primary Slow Orthostatic Tremor: A Premotor Sign of Parkinson’s Disease?
Model-based optimization of controlled release formulation of levodopa for Parkinson’s disease
Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
Cerebellar involvement in Parkinson’s disease resting tremor
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs
Charakteristika der Unified Parkinson’s Disease Rating Scale im Rahmen der Levodopa-Response
Levodopa-Responsive Primary Slow Orthostatic Tremor: A Premotor Sign of Parkinson’s Disease?
Model-based optimization of controlled release formulation of levodopa for Parkinson’s disease